Genistein decreases mouse liver lnfection by <i>P. berghei</i> ANKA sporozoites. by Margarida Cunha-Rodrigues (65513)

Losartan decreases vessel size but not effect microvessel density or pericyte recruitment in Pan02 tumors grown in <i>SPARC−/−</i> animals. by Shanna A. Arnold (183991)

Follistatin expression is decreased and the MAPK signaling pathway is activated in <i>Med1^epi−/−</i> mice keratinocytes <i>in vitro</i>. by Fumihito Noguchi (615295)

Changes related to kidney staining in UUO mouse model. by Wencheng Jin (13136262)

Changes associated with kidney fibrosis in TGF- by Wencheng Jin (13136262)

Characterization of passage 1 (P1) bone marrow-derived canine mesenchymal stromal cells (cMSCs). by Melissa A. MacIver (12850566)

Met inhibits the differentiation of BMMs into osteoclasts <i>in vitro</i>. by Haohui Guo (6516638)

PV1 treatment ameliorates EAU. by Pedro Henrique Papotto (791904)

IFNγ and CXCL10 has a key role in CD20-TCB T cell recruitment. by Floriana Cremasco (5580266)

“…****p<0.0001. d) IFNγ and (e) CXCL10 protein quantification by multiplex analysis of supernant derived from co-culture of WSU DLCL2 cells with decreasing amounts of T cells stimulated with 200 ng/ml of CD20-TCB for 16 hours. …”

Image_2_Baseline Testosterone Predicts Body Composition and Metabolic Response to Testosterone Therapy.jpeg by FNU Deepika (11881310)

Image_1_Baseline Testosterone Predicts Body Composition and Metabolic Response to Testosterone Therapy.jpeg by FNU Deepika (11881310)

Table_1_Baseline Testosterone Predicts Body Composition and Metabolic Response to Testosterone Therapy.docx by FNU Deepika (11881310)

Image1_Potential profound fluctuation in tacrolimus concentration on consumption of pomegranate rind extract: A Pharmacokinetic Experiment.JPEG by Ritu Karwasra (4776858)

“…</p><p>Results: The findings depict that in comparison with the TAC (3 mg/kg) alone group with the 7-day repetitive (7-R) PRE (200 mg/kg) dosing, the Cmax was found to be 9.03 ± 1.21 ng/ml; AUC from time zero to infinity (AUC0-∞), 61.91 ± 17.37 ngh/ml, while the TAC (3 mg/kg) + PRE group exhibited an increase in PK parameters of TAC (Cmax 22.48 ± 3.07 ng/ml; AUC0-∞ 153.08 ± 13.24 ng h/ml). …”

DataSheet1_Potential profound fluctuation in tacrolimus concentration on consumption of pomegranate rind extract: A Pharmacokinetic Experiment.docx by Ritu Karwasra (4776858)

“…</p><p>Results: The findings depict that in comparison with the TAC (3 mg/kg) alone group with the 7-day repetitive (7-R) PRE (200 mg/kg) dosing, the Cmax was found to be 9.03 ± 1.21 ng/ml; AUC from time zero to infinity (AUC0-∞), 61.91 ± 17.37 ngh/ml, while the TAC (3 mg/kg) + PRE group exhibited an increase in PK parameters of TAC (Cmax 22.48 ± 3.07 ng/ml; AUC0-∞ 153.08 ± 13.24 ng h/ml). …”

Table_2_A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravir.docx by Andrea R. Thurman (5286005)

Table_1_A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravir.docx by Andrea R. Thurman (5286005)

Human quad liver-on-chip system as a tool toward bridging the gap between animals and humans regarding toxicology and pharmacology of a cannabidiol-rich cannabis extract by Laura E. Ewing (5470541)

“…For this purpose, C57BL6/J male mice were subjected to dosing with either 0, 61.5, 184.5, or 615 mg/kg of CRCE for 10 days. The liver-on-chip system, incorporating human primary hepatocytes, sinusoidal endothelial cells, as well as Kupffer and stellate cells was subjected to 0, 300, 1,200, or 4,400 ng/mL of CRCE (8 h exposure followed by 16 h washout) for 5 days. …”

DataSheet_1_A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravir.docx by Andrea R. Thurman (5286005)

Supplementary Material for: Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a... by figshare admin karger (2628495)

“…At randomization, iPTH had to be 300-<1,200 pg/mL, 25D <50 ng/mL, corrected serum calcium <9.8 mg/dL and phosphorus <6.5 mg/dL. …”

Additional file 2 of Single-cell profiling reveals periosteal signatures of impaired periosteal cells proliferation in a drill-hole model of type 2 diabetes by Xing Ji (3096735)

“…Effect of FGL2 on Osteoblast Proliferation Under Normal and High Glucose Conditions. A. Osteoblasts were treated with vehicle or varying concentrations of FGL2 (50, 200 ng/mL) under normal (vehicle) and high glucose (4.5 mg/mL) conditions, and relative cell proliferation was assessed after 48 h to compare the effects under these different conditions. …”